Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents
Launched by TEL AVIV UNIVERSITY · Apr 7, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether Shiatsu therapy, a form of massage that focuses on pressure points, can help improve the quality of life for children and teenagers dealing with chronic pain that doesn't come from inflammation. The main goal is to see if adding weekly Shiatsu sessions to their regular treatment can make a difference in how they feel and function in their daily lives.
To participate, children and teens aged 10 to 18 must have a diagnosis of chronic pain that is not related to inflammation and be receiving care at the Pediatric Rheumatology or Pediatric Pain Clinics in Tel Aviv. Participants will continue their usual treatments and attend a 30-minute Shiatsu session once a week for six weeks. They will also fill out questionnaires about their quality of life and how their pain affects their families before, during, and after the therapy. This study is not yet recruiting participants, but it aims to involve about 40 young people who meet the criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children and adolescents aged 10-18 years
- • Diagnosed with non-inflammatory chronic pain syndromes
- • Actively followed by the Pediatric Rheumatology and/or Pediatric Pain Clinics at Tel Aviv Sourasky Medical Center (at least twice a year)
- • Informed consent signed by at least one legal guardian (or both guardians in cases of separated parents)
- • If participant is 16 years or older, they must also sign the informed consent
- Exclusion Criteria:
- • Informed consent cannot be obtained from the participant or their legal guardians
- • Legal guardians unable to provide informed consent
- • Patients with severe conditions (e.g., bone metastasis)
- • Patients unable to participate in Shiatsu therapy sessions
- • Participation in Shiatsu therapy within 6 months prior to study enrollment
- • Participant or legal guardian refuses participation
About Tel Aviv University
Tel Aviv University (TAU) is a leading research institution in Israel, renowned for its commitment to advancing knowledge and innovation across various fields, including medicine and biomedical research. With a strong emphasis on interdisciplinary collaboration, TAU conducts cutting-edge clinical trials aimed at improving healthcare outcomes and developing novel therapeutic strategies. The university's robust network of researchers, state-of-the-art facilities, and partnerships with healthcare organizations enable it to contribute significantly to the global medical research community, fostering advancements that address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
תל אביב, , Israel
Patients applied
Trial Officials
Merav Heshin-Bekenstein, MD
Principal Investigator
Dana Dwek Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported